Delivery Order SPE2DE21D7010-SPE2D625F63XK
- Not listed
- This federal contract award, valued at $1,956.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment mechanism, with an ultimate completion date of May 14, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, has established itself as a key supplier of...
- This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of May 23, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized spinal medical...
- This federal contract award is a delivery order worth $23,660.61 issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of July 21, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized spinal medical...
- This federal contract award, valued at $12,969.84, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price with economic price adjustment pricing type and an ultimate completion date of May 16, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized medical...
- This federal contract award of $10,383.60 was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of February 7, 2025. Nuvasive, Inc. is the prime contractor for this award, which is not designated as a set-aside contract. The company is a subsidiary of...
- This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Delivery Order under a Fixed Price with Economic Price Adjustment pricing type, with a period of performance through February 10, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports...
- This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and the ultimate completion date is April 18, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract does not have a...
- This is a federal contract award to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract, valued at $20,821.36, is a fixed-price delivery order with economic price adjustment, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is not associated with any set-aside designation, indicating Nuvasive competes in open market procurements. The contract involves the delivery of specialized spinal medical technologies,...
- This federal contract award is for $8,427.00 and was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price with economic price adjustment pricing type and an ultimate completion date of June 4, 2025. The contract is not associated with any set-aside designations, indicating Nuvasive successfully competed in an open market procurement....
- This federal contract award, valued at $2,009.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Delivery Order under Contract SPE2DE21D7010 and SPE2D625F79WY, with a completion date of January 6, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract involves the delivery of a range of...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D625F63XKDelivery Order
This federal contract award is for $20,821.36 and was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a delivery order with a fixed price plus economic price adjustment pricing type, and has an ultimate completion date of January 31, 2025. The contract does not have a set-aside designation, indicating Nuvasive, Inc. competed for the award in an open market procurement. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract primarily supports orthopedic, neurological, and reconstructive surgeries at Department of Veterans Affairs (VA) and Department of Defense (DoD) medical facilities. Nuvasive, Inc. holds an $8 million Blanket Purchase Agreement (BPA) with the Defense Health Agency, which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle allowing DHA facilities to efficiently access the company's portfolio of spinal medical devices and instruments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.8k | 1/30/25 |